» Articles » PMID: 23811963

Longitudinal Changes in Left Ventricular Stiffness: a Community-based Study

Overview
Journal Circ Heart Fail
Date 2013 Jul 2
PMID 23811963
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cross-sectional studies suggest that left ventricular (LV) and arterial elastance (stiffness) increase with age, but data examining longitudinal changes within human subjects are lacking. In addition, it remains unknown whether age-related LV stiffening is merely a reaction to arterial stiffening or caused by other processes.

Methods And Results: Comprehensive echo-Doppler cardiography was performed in 1402 subjects participating in a randomly selected community-based study at 2 examinations separated by 4 years. From this population, 788 subjects had adequate paired data to determine LV end-systolic elastance (Ees), end-diastolic elastance (Eed), and effective arterial elastance. Throughout 4 years, blood pressure, arterial elastance, and LV mass decreased, coupled with significantly greater use of antihypertensive medications. However, despite reductions in arterial load, Ees increased by 14% (2.10±0.67-2.26±0.70 mm Hg/mL; P<0.0001) and Eed increased by 8% (0.13±0.03-0.14±0.04 mm Hg/mL; P<0.0001). Increases in Eed were greater in women than men, whereas Ees changes were similar. Age-related increases in Ees and Eed were correlated with changes in body weight, but were similar in subjects with or without cardiovascular disease. Changes in Ees were correlated with Eed (r=0.5; P<0.0001), but not with other measures of contractility, indicating that the increase in Ees was reflective of passive stiffening rather than enhanced systolic function.

Conclusions: Despite reductions in arterial load with medical therapy, LV systolic and diastolic stiffness increase over time in humans, particularly in women. In addition to blood pressure control, therapies targeting load-independent ventricular stiffening may be effective to treat and prevent age-associated cardiovascular diseases, such as heart failure.

Citing Articles

The Balance Between the Natriuretic Peptides and the Renin-Angiotensin-Aldosterone System in the Preservation of Ideal Cardiovascular Health.

Rubattu S, Gallo G, Volpe M J Clin Med. 2025; 14(2).

PMID: 39860634 PMC: 11766086. DOI: 10.3390/jcm14020626.


Metformin Improves Glycemic Control and Postprandial Metabolism and Enhances Postprandial Glucagon-Like Peptide 1 Secretion in Patients With Type 2 Diabetes and Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial.

Melenovsky V, Hoskova E, Velebova K, Veleba J, Borlaug B, Benes J Clin Diabetes. 2025; 43(1):23-32.

PMID: 39829685 PMC: 11739370. DOI: 10.2337/cd24-0003.


Cardiorenal Syndrome in Heart Failure with Preserved Ejection Fraction: Insights into Pathophysiology and Recent Advances.

Khandait H, Sodhi S, Khandekar N, Bhattad V Cardiorenal Med. 2025; 15(1):41-60.

PMID: 39756385 PMC: 11844688. DOI: 10.1159/000542633.


The Oxygen Cascade According to HFpEF Likelihood: A Focus on Sex Differences.

Verwerft J, Foulkes S, Bekhuis Y, Moura-Ferreira S, Falter M, Hoedemakers S JACC Adv. 2024; 3(7):101039.

PMID: 39130052 PMC: 11313028. DOI: 10.1016/j.jacadv.2024.101039.


Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach.

Stoicescu L, Crisan D, Morgovan C, Avram L, Ghibu S Int J Mol Sci. 2024; 25(2).

PMID: 38255869 PMC: 10815792. DOI: 10.3390/ijms25020794.


References
1.
Zieman S, Melenovsky V, Kass D . Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005; 25(5):932-43. DOI: 10.1161/01.ATV.0000160548.78317.29. View

2.
Kass D . Assessment of diastolic dysfunction. Invasive modalities. Cardiol Clin. 2000; 18(3):571-86. DOI: 10.1016/s0733-8651(05)70162-4. View

3.
van Heerebeek L, Borbely A, Niessen H, Bronzwaer J, van der Velden J, Stienen G . Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006; 113(16):1966-73. DOI: 10.1161/CIRCULATIONAHA.105.587519. View

4.
Selby D, Palmer B, LeWinter M, Meyer M . Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. J Am Coll Cardiol. 2011; 58(2):147-54. PMC: 3147146. DOI: 10.1016/j.jacc.2010.10.069. View

5.
Wachtell K, Bella J, Rokkedal J, Palmieri V, Papademetriou V, Dahlof B . Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation. 2002; 105(9):1071-6. DOI: 10.1161/hc0902.104599. View